This past April,we were proud to help represent Canada at #ADPD2025.

While there, we spoke with Parkinson Canada-funded researcher Dr. Margaux Teil about advancing #Parkinson’s research, global collaboration, and the power of lived experience.

📖 parkinson.ca/an-interview...

#ParkinsonsResearch

Leqembi in the Clinic: In Early Reports, ARIA Rates Echo Trials | ALZFORUM

With #lecanemab approval in 🇪🇺 many challenges are expected for its introduction in the clinic

Nice #Alzforum overview on #ADPD2025 ppts on anti-amyloid therapies experience in non-🇪🇺 for #Alzheimer also covering our survey on how ready are we to deal with #ARIA in 🇪🇺

www.alzforum.org/news/confere...

Enhancing diagnostic precision in Alzheimer's disease: Impact of comorbidities on blood biomarkers for clinical integration At AD/PD 2025, Makrina Daniilidou presented research on how cardiovascular and metabolic comorbidities affect the performance of blood-based biomarkers in Alzheimer’s disease diagnosis. We spoke with ...

Makrina Daniilidou presented how comorbidities affect the reliability of blood-based biomarkers for Alzheimer’s diagnosis at #ADPD2025,
We spoke with her about the implications for clinical use & @ihieurope.bsky.social's @ihi-prominent.bsky.social project.
www.ihi-prominent.eu/enhancing-di...

Discover how #ADPD2025 tackled everything from biomarkers to gut-brain signalling 🎧 @isabelscst.bsky.social @alzsocresearch.bsky.social @susanrohde.bsky.social @emmafgarland.bsky.social @annamallach.bsky.social
@loukiakatsouri.bsky.social @ajh1269.bsky.social

podfollow.com/dementia-res...

Cognito’s Gamma Sensory Stimulation Leads to Preserved Corpus Callosum Structure in Alzheimer Disease The Spectris device demonstrated preserved corpus callosum structure and correlated sensory-evoked gamma oscillations in patients with Alzheimer disease, highlighting its potential neuroprotective eff...

New data from #ADPD2025 📊

Cognito’s Spectris device showed 40 Hz brainwave activation + preserved corpus callosum structure in AD pts vs ADNI controls 🧠 Promising noninvasive tech for #Alzheimers.

More here 👉 www.neurologylive.com/view/cognito...

AD/PD 2025 = science, serendipity & surprises!

✨ Poster chats turned collaborations
👩‍🔬 PhD students stealing the spotlight
💚 Standing ovation for a carers story

🎧 #ADPD2025 #DementiaResearcher @emmafgarland.bsky.social @isabelscst.bsky.social
@susanrohde.bsky.social

youtu.be/PghjSzaamnc

Just back from Vienna with stories of tau, astrocytes, and biomarker battles! 🧠✨ Part One of our #ADPD2025 video podcast is live. @loukiakatsouri.bsky.social @annamallach.bsky.social @ajh1269.bsky.social

youtu.be/fOsiGjXvBPA

🧠🎙️ New Podcasts from #ADPD2025 2-part specials packed with research & science updates @isabelscst.bsky.social @alzsocresearch.bsky.social @susanrohde.bsky.social @emmafgarland.bsky.social @annamallach.bsky.social @loukiakatsouri.bsky.social

Part One - pod.fo/e/2c6ee6
Part Two - pod.fo/e/2c6ee5

Who needs Netflix when you’ve got two packed podcast episodes sharing highlights from the #ADPD2025 Conference?
Grab a cuppa and get your neuro fix ☕🧬

Part One - youtu.be/fOsiGjXvBPA
Part Two - youtu.be/PghjSzaamnc

Catch part one of our two-part special on #ADPD2025! Early video highlights from the conference – key takeaways, hot topics, and more: youtu.be/fOsiGjXvBPA

Thank you for visiting this StressMarq booth at #ADPD2025. The scientific method used to prepare StressMarq tau oligomers is published in the literature. We'd be happy to share that paper with you. Please email us at techsupport@stressmarq.com if you'd like the reference.

What a week at the #ADPD2025 conference in Vienna!

A key takeaway? There’s growing momentum around novel #biomarker discovery and using targeted #proteomics to develop fit-for-purpose assays — from AD and PD to ALS and beyond.

If we missed you at the booth, let’s fix that! hubs.la/Q03gNJFz0

A huge thank you to everyone who attended "Belvedere At Night" — our ISMND members-only event at #ADPD2025! 🌙✨ We loved seeing you there and hope you had an unforgettable night!

Feeling inspired after a great week at #ADPD2025 in Vienna🇦🇹

Presented survey results from @esnr.bsky.social
& @ean.org working group inquiring how ready are we to deal with #ARIA

Also, excited to see the ppts linked to my sabbatical period at
@amsterdamumc.bsky.social with #FrederikBarkhof

Profile – Susan Rohde, Amsterdam UMC - DEMENTIA RESEARCHER Susan Rohde is a Neurobiologist and PhD Student at UMC Amsterdam interested in brain aging and related diseases working on the Dutch #100plusStudy

Our #ADPD2025 highlight podcasts drop later this week. Meet first-time new contributor @susanrohde.bsky.social, Neurobiologist and PhD Student at UMC Amsterdam interested in brain aging and related diseases working on the Dutch #100plusStudy

www.dementiaresearcher.nihr.ac.uk/profile-susa...

Profile – Dr Emma Garland, The University of Sheffield - DEMENTIA RESEARCHER Dr Emma Garland is a Research Associate at The University of Sheffield researching Alzheimer’s disease protein pathogenesis.

We're putting the final touches to our #ADPD2025 highlights podcasts! We'd love for you to meet our new first-time contributors. 1st @emmafgarland.bsky.social, Research Associate, University of Sheffield exploring Alzheimer’s protein pathogenesis.

www.dementiaresearcher.nihr.ac.uk/profile-dr-e...

This past week, I was very grateful to have the opportunity to present at the AD/PD - Advances in Science & Therapy conference in Vienna, Austria. It was such a lovely week, learning from and connecting with so many talented scientists. #ADPD2025

Anyone else #ADPD2025 ???

Had such a great and inspiring time at #ADPD2025 in the beautiful Vienna. Thanks for all the great science, inspiring chats and new people I've met. This week was good for my scientific spirit! 🧠✨

Another fantastic #ADPD2025 conference in Vienna, Austria where the scientific community came together through mutual passion and commitment to humanity. The final day, April 5, during #handsoff across the US; I was learning about the Austria Secession movement. We will persist, as we always have.

#ADPD2025 was exhausting 😴 but so thrilling 🤩 The discussions really energized me! ⚡🔋

I got to chat w/ collaborators, mentors & promising students. 💬

And the city of Vienna is beautiful!! 🏛️👑🎻🖼️

I returned to Boston feeling inspired, creative & motivated. 💪🏻🙌🏻

In the pic w/ PI @winhide.bsky.social

My first #ADPD2025 was great! Some fantastic science being discussed! It was great to present my work on neuronal vulnerability to different Abeta ratios. Hosted in the beautiful city of Vienna🧠🇦🇹☀️

Had a great time at #ADPD2025! Thrilled that my data was presented and received positive feedback. Looking forward to future collaborations and insights!

So proud of my colleagues @larikili.bsky.social, @lrehra.bsky.social and @marijabani.bsky.social and excited to see their work being appreciated and their data being presented on the last day of #adpd2025.

It’s a wrap for #ADPD2025 in #Vienna. See y’all in #Copenhagen for #ADPD2026 🤓🧠🧫🧬💊🦠💉🌡️🩺🔬 @adpdnet

All good things must come to an end -- and while the Acumen team is sad to leave the #ADPD2025 Conference, it’s been a wonderful week of sharing knowledge and innovation in the #Alzheimer’s field. We’ll see you all next year!

Amazing food at networking dinners at #ADPD2025

Thank you Vienna! Came for #adpd2025, want to stay for the scenery and pastries!

Thanks for awesome science & chats #ADPD2025! 🇦🇹
Now to nerd out on my first love, modern art 😍🧠

Such a bonus to see Hundertwasser’s architecture alongside this conference, many years after choosing to study his work at GCSE. Looking forward to some Klimt too! ✨

It’s only taken 5 days but I think I’ve finally managed to navigate to Hall B and Hall C with above chance accuracy at #ADPD2025 😂😂

This whole centre is like a cognitive testing maze, and I’ve been put in the sleep deprivation condition 🥲😅